Haruhiko Fukuda
Papers
3
Total Citations
16
H-Index
2
About
Haruhiko Fukuda is a leading figure in surgical oncology, whose work has profoundly shaped the landscape of minimally invasive cancer surgery in Japan. His research centers on establishing the oncologic safety and efficacy of laparoscopic and robotic approaches for complex gastrointestinal and gynecologic malignancies. Fukuda’s major contributions are driven by large-scale, multi-institutional randomized and confirmatory trials under the Japan Clinical Oncology Group (JCOG). Notably, his recent phase III study (JCOG2202, 9 citations) directly compares minimally invasive distal pancreatectomy to open surgery for pancreatic cancer, addressing a critical gap in evidence regarding oncologic outcomes. He has also pioneered efforts to de-escalate surgical invasiveness, as demonstrated by his confirmatory trial of modified radical hysterectomy for early-stage cervical cancer (JCOG1101, 5 citations), which seeks to reduce morbidity without compromising survival. Further, his phase II trial on laparoscopic/robotic total gastrectomy with spleen-preserving hilar dissection (JCOG1809, 2 citations) challenges the standard of routine splenectomy for proximal gastric cancer. Through these methodologically rigorous studies, Fukuda is systematically redefining surgical standards, balancing radical oncologic principles with the benefits of minimally invasive techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3